1. Home
  2. FTHY vs SENS Comparison

FTHY vs SENS Comparison

Compare FTHY & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Trust High Yield Opportunities 2027 Term Fund

FTHY

First Trust High Yield Opportunities 2027 Term Fund

SELL

Current Price

$13.01

Market Cap

493.5M

Sector

Finance

ML Signal

SELL

Logo Senseonics Holdings Inc.

SENS

Senseonics Holdings Inc.

SELL

Current Price

$9.32

Market Cap

397.1M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
FTHY
SENS
Founded
2020
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Industrial Machinery/Components
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
493.5M
397.1M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
FTHY
SENS
Price
$13.01
$9.32
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
★ $13.67
AVG Volume (30 Days)
113.0K
★ 554.7K
Earning Date
01-01-0001
11-09-2026
Dividend Yield
★ 10.93%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $16,389,000.00
Revenue This Year
N/A
$82.21
Revenue Next Year
N/A
$55.63
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 19.85
52 Week Low
$12.49
$4.79
52 Week High
$14.34
$10.64

Technical Indicators

Market Signals
Indicator
FTHY
SENS
Relative Strength Index (RSI) 58.29 57.57
Support Level $12.93 $8.45
Resistance Level $13.11 $10.07
Average True Range (ATR) 0.18 0.53
MACD 0.05 0.01
Stochastic Oscillator 90.00 98.13

Price Performance

Historical Comparison
FTHY
SENS

About FTHY First Trust High Yield Opportunities 2027 Term Fund

FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND is a diversified, closed-end management investment company. The investment objective of the fund is to provide current income. The fund invests a majority of its managed assets in high-yield debt securities of any maturity that are rated below investment grade at the time of purchase or unrated securities. Its investment portfolio comprises corporate bonds and notes, senior floating-rate loan interests, foreign corporate bonds and notes, money market funds, and other instruments across various industries.

About SENS Senseonics Holdings Inc.

Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.

Share on Social Networks: